Chuan Wang

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia

Zhimin Shao, Da Pang, Hongjian Yang et al. · JAMA Oncology · 2019 · 184 citations · Full text

Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients

Gangqin Xi, Wenhui Guo, Deyong Kang et al. · Theranostics · 2021 · 120 citations · Full text

SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer

Chuan Wang, Paul Jedlicka, Aaron Patrick et al. · Journal of Clinical Investigation · 2012 · 118 citations · Full text

Breast Oncology, Immunology, Cell Proliferation +16

Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways

Ritsuko Iwanaga, Chuan Wang, Douglas S. Micalizzi et al. · Breast Cancer Research · 2012 · 90 citations · Full text

Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

Jiong Wu, Zefei Jiang, Zhenzhen Liu et al. · BMC Medicine · 2022 · 70 citations · Full text